1.1414
+0.0952
+(9.10%)
As of 9:06:32 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 3 | 6 | 7 |
| Avg. Estimate | 11.7M | 30.67M | 62.48M | 73.52M |
| Low Estimate | 200k | 10M | 51.4M | 20.84M |
| High Estimate | 20M | 70M | 71M | 200M |
| Year Ago Sales | 2.04M | 481k | 176.23M | 62.48M |
| Sales Growth (year/est) | 472.97% | 6,275.61% | -64.54% | 17.66% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GBY.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/27/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/2/2025 |
| Maintains | Jefferies: Buy to Buy | 12/31/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 12/31/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/20/2024 |
Related Tickers
NMLSD Restart Life Sciences Corp.
0.0356
-69.44%
NVV1.DU Novavax Inc
8.62
+2.54%
MRES Institute of Biomedical Research Corp.
0.0160
-3.03%
TPIA Mycotopia Therapies, Inc.
0.0265
-10.17%
ENDV Endonovo Therapeutics, Inc.
0.0003
+50.00%
NFX.L Nuformix plc
0.0800
+6.67%
TYRA Tyra Biosciences, Inc.
14.77
+0.37%
MLYS Mineralys Therapeutics, Inc.
10.42
+1.46%
CAMP CAMP4 THERAPEUTICS CORPORATION
5.90
0.00%
OKUR OnKure Therapeutics, Inc.
6.05
+3.77%